-
2024 CUDA丨Dr. Tie Zhong: New Endocrine Therapies Improve Prognosis in mHSPC, Optimizing Precision Treatment Through Stratified Approaches
The 2024 Annual Meeting of the Urological Surgeons Branch of the Chinese Medical Association (CUDA) was held in Xi’an from August 8 to 11, 2024. The conference was hosted by the Chinese Medical Association and the CUDA Urological Surgeons Branch, with the Air Force Medical University Xijing Hospital serving as the organizer and the Shaanxi…
-
2024 CUDA丨Dr. Jian Huang: Exploring the Potential Benefits of Robot-Assisted Function-Preserving Radical Cystectomy for Bladder Cancer Patients
Robot-assisted radical cystectomy is playing an increasingly significant role in the treatment of bladder cancer. At the 2024 Annual Meeting of the Urological Surgeons Branch of the Chinese Medical Association (CUDA) held in Xi’an from August 8 to 11, Dr. Jian Huang from Sun Yat-sen Memorial Hospital, Sun Yat-sen University, shared his insights on “Robot-Assisted…
-
2024 CUDA丨Dr. Wei Yu: Optimal ADC Strategies in the Systemic Treatment of Urothelial Carcinoma
Urothelial carcinoma (UC) is one of the most common malignancies in the urinary system. With the increasing availability of ADC (antibody-drug conjugate) drugs in clinical practice, optimizing ADC drug selection and combination therapies, as well as managing treatment-related adverse events, have become critical issues. Following the successful 2024 Annual Meeting of the Urological Surgeons Branch…
-
2024 CUDA丨Dr. Xiangjun Lyu: Addressing Incontinence Early, Enhancing Pelvic Floor Disease Outcomes with Robotic Surgery
The 2024 Annual Meeting of the Urological Surgeons Branch of the Chinese Medical Association (CUDA) was held in Xi’an from August 8 to 11, 2024. The conference was hosted by the Chinese Medical Association and the CUDA Urological Surgeons Branch, with the Air Force Medical University Xijing Hospital serving as the organizer and the Shaanxi…
-
The First Mid-Term Milestone of the End TB Strategy: Global Progress and Key Findings
Editor’s Note: Tuberculosis (TB) remains a significant public health challenge worldwide, particularly in economically underdeveloped regions. Although progress has been made in TB diagnosis and treatment in recent years, factors…
-
Are OTC Eye Drops Safe? CRPA Outbreaks in Multiple U.S. States Trace Back to Artificial Tears
Editor’s Note: Artificial tears are substitutes that mimic the composition of natural tears, providing lubrication to the eyes and alleviating symptoms of dry eye, such as pain and burning. However,…
-
Cutting-edge Bi-monthly: July Literature Digest (Part 1)
In this era of information explosion, how can one quickly access the latest developments in the field? Here, we select the latest literature in the field every month, focusing on hot topics, comprehensively interpreting new advances in hematologic diseases, and helping you stay at the forefront of the disease field. Let’s track the latest trends…
-
News Express | Leukemia Research Highlights from Blood Reviews: A Six-Month Overview
The “News Express” column serves as a bridge between cutting-edge research and clinical practice, enabling hematology enthusiasts and professionals to swiftly capture industry trends, ignite innovative thinking, and broaden their professional perspectives. Hematology Frontier carefully selects the latest hematological research findings from top global journals. Each article is a brilliant spark of science and clinical…
Connecting Medical Expertise through Media